Article Details

Price Target Raised on Biopharma Achieving Positive Atopic Dermatitis Study Results

Retrieved on: 2021-06-23 16:18:45

Tags for this article:

Click the tags to see associated articles and topics

Price Target Raised on Biopharma Achieving Positive Atopic Dermatitis Study Results. View article details on hiswai:

Excerpt

This gives the biopharma enough funds to advance ATI-1777 through a Phase 2b study, likely to start later this year or early next, as well as ATI-450.

Article found on: www.streetwisereports.com

View Original Article

This article is found inside other hiswai user's workspaces. To start your own collection, sign up for free.

Sign Up